We are live on ! Find out more
NSPRZ

InspireMD, Inc. Series B Warrants

Delisted

NSPRZ was delisted on the 14th of March, 2022.

5 hedge funds and large institutions have $97K invested in InspireMD, Inc. Series B Warrants in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

978% more capital invested

Capital invested by funds: $9K → $97K (+$88K)

25% more funds holding

Funds holding: 45 (+1)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
AFM
1
Anson Funds Management
Texas
$85K +$3.2K +250,000 New
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$7K -$1.62K -126,531 -19%
UBS Group
3
UBS Group
Switzerland
$3K +$1.13K +88,493 +88%
Citadel Advisors
4
Citadel Advisors
Florida
$1K -$14 -1,100 -2%
VF
5
Virtu Financial
New York
$1K +$22 +1,714 +5%

NSPRZ Hedge Fund Activity: Q4 2020 in Review

5 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q4 2020, worth a combined $97K — up 978% from $9K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new NSPRZ positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 2 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $3.2K. The largest seller was Susquehanna International Group, cutting an estimated $1.62K.

  • 5 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q4 2020, up from 4 in Q3 2020.
  • Funds reported $97K of InspireMD, Inc. Series B Warrants stock for Q4 2020, up 978% quarter-over-quarter.
  • 1 fund opened new InspireMD, Inc. Series B Warrants positions in Q4 2020 and 0 closed out, a net change of +1 holder.
  • The largest InspireMD, Inc. Series B Warrants buyer in Q4 2020 was Anson Funds Management, an estimated $3.2K added.
  • The largest InspireMD, Inc. Series B Warrants seller in Q4 2020 was Susquehanna International Group, an estimated $1.62K sold.

Based on aggregated 13F filings for Q4 2020.